FAP and neoplasm: In order to simultaneously target cancer cells through virus-mediated oncolysis and to re-direct immune responses towards tumor stroma fibroblasts, we engineered the genome of the oncolytic adenovirus ICO15K to express a FAP-targeting BiTE (FBiTE) (named as ICO15K-FBiTE).